Measurement of pre- and post-synaptic proteins in cerebral cortex: Effects of post-mortem delay

Journal of Neuroscience Methods

Volumn 139, Issue 2, 2004, Pages 153-159

  Siew, Lai Khai ^a   Love, Seth ^b   Dawbarn, David ^a   Wilcock, Gordon Keith ^a   Allen, Shelley Jane ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b FRENCHAY HOSPITAL   (United Kingdom)

Author keywords

ELISA; Post mortem delay; PSD 95; Synaptophysin; Syntaxin

Indexed keywords

BRAIN PROTEIN; POSTSYNAPTIC DENSITY PROTEIN 95; SYNAPTOPHYSIN; SYNTAXIN;

ANIMAL TISSUE; ARTICLE; AUTOPSY; BRAIN CORTEX; BRAIN TISSUE; CONTROLLED STUDY; COOLING; ENZYME LINKED IMMUNOSORBENT ASSAY; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ROOM TEMPERATURE; SYNAPSE; TEMPORAL CORTEX;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CEREBRAL CORTEX; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; POSTMORTEM CHANGES; QA-SNARE PROTEINS; RATS; SYNAPSES; SYNAPTOPHYSIN; TIME FACTORS;

EID: 5644235607     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2004.04.020     Document Type: Article

References (17)

1. Alford M., Masliah E., Hansen L.A., Terry R.D. A simple dot-immunobinding assay for quantification of synaptophysin-like immunoreactivity in human brain. J. Histochem. Cytochem. 42:1994;283-287
2. Allen S.J., MacGowan S.H., Tyler S., Wilcock G.K., Robertson A.G.S., Holden P.H., et al. Reduced cholinergic function in normal and Alzheimer's disease brain is associated with apolipoprotein E4 genotype. Neurosci. Lett. 239:1997;33-36
3. Bigio E.H., Vono M.B., Satumtira S., Adamson J., Sontag E., Hynan L.S., White C.L. III, Baker M., Hutton M. Cortical synapse loss in progressive supranuclear palsy. J. Neuropathol. Exp. Neurol. 60:2001;403-410
4. Brun A., Liu X., Erikson C. Synapse loss and gliosis in the molecular layer of the cerebral cortex in Alzheimer's disease and in frontal lobe degeneration. Neurodegeneration. 4:1995;171-177
5. Brunger A.T. Structure of proteins involved in synaptic vesicle fusion in proteins. Ann. Rev. Biophys. Biomol. Struct. 30:2001;157-171
6. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:1993;921-923
7. DeKosky S.T., Scheff S.W. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann. Neurol. 27:1990;457-464
8. Dickson D.W., Crystal H.A., Bevona C., Honer W., Vincent I., Davies P. Correlations of synaptic and pathological markers with cognition of the elderly. Neurobiol. Aging. 16:1995;285-298
9. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell. 11:2003;257-269
10. Gibson P.H. EM study of the numbers of cortical synapses in the brains of ageing people and people with Alzheimer-type dementia. Acta Neuropathol. (Berl.). 62:1983;127-133
11. Hynd M.R., Lewohl J.M., Scott H.L., Dodd P.R. Biochemical and molecular studies using human autopsy brain tissue. J. Neurochem. 85:2003;543-562
12. Liu X, Brun A. Synaptophysin immunoreactivity is stable 36 h postmortem. Dementia; 1995. p. 211-7.
13. Love S., Matthews S.M., MacGowan S.H., Wilcock G.K. Possession of apoE2 is associated with significantly increased synaptophysin immunolabelling in the superior temporal gyrus. Neuropathol. Appl. Neurobiol. 26:2000;203
14. Masliah E., Mallory M., Hansen L.A., SeTeresa R., Terry R.D. Quantitative synaptic alterations in the human neocortex during normal aging. Neurology. 43:1993;192-197
15. Mukaetova-Ladinska E.B., Garcia-Siera F., Hurt J., Gertz H.J., Xuereb J.H., Hills R., et al. Determination of synapsin I and synaptophysin in body fluids by two-site enzyme-linked immunosorbent assays. J. Immunol. Meth. 213:1998;191-199
16. Schneider S., Buchert M., Georgiev O., Catimel B., Halford M., Stacker S.A., et al. Mutagenesis and selection of PDZ domains that bind new protein targets. Nat. Biotech. 17:1999;170-175
17. Teasdale G.M., Nicoll J.A., Murray G., Fiddes M. Association of apolipoprotein E polymorphism with outcome after head injury. Lancet. 350:1997;1069-1071